Hypertension in adult polycystic kidney disease: a narrative review

被引：0

作者：

Mian, Sarah ^{[1
]}

Acharya, Yogesh ^{[1
]}

Dahal, Ranjan ^{[2
]}

机构：

[1] Avalon Univ, Sch Med, Curacao, Neth Antilles

[2] St Peters Univ Hosp, New Brunswick, NJ 08901 USA

来源：

JOURNAL OF RENAL INJURY PREVENTION | 2019年 / 8卷 / 02期

关键词：

Adult polycystic kidney disease; Hypertension; Antihypertensive agents; Prevention and control; Renin-angiotensin-aldosterone system; End stage renal disease; Glomerular filtration rate; Chronic kidney disease; CONVERTING-ENZYME-INHIBITORS; BLOOD-PRESSURE; ENDOTHELIN; PROGRESSION; ADPKD;

D O I：

10.15171/jrip.2019.23

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disorder that impacts approximately 12 million worldwide. It is characterized by bilateral kidney enlargement and cystic growth. Hypertension (HTN) is a focal point in the management of ADPKD and is linked to a faster progression to end stage renal disease. Current novel therapies have proven to reduce the progression of renal damage. The ideal goal is to minimize risk through preventative studies and pharmacology to further increase life expectancy and quality. The purpose of this article is to highlight the importance of blood pressure management in ADPKD and review current literature to determine the most effective preventative pharmacotherapy.

引用

页码：122 / 126

页数：5

共 50 条

[31] Autosomal Dominant Polycystic Kidney Disease
Suarez, Maria Lourdes Gonzalez
Titan, Silvia
Dahl, Neera K.
ADVANCES IN KIDNEY DISEASE AND HEALTH, 2024, 31 (06): : 496 - 503
[32] Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children
Lucchetti, L.
Chinali, M.
Emma, F.
Massella, L.
FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
[33] New options in the treatment of autosomal dominant polycystic kidney disease
Kazancioglu, Rumeyza
Gursu, Meltem
RENAL FAILURE, 2015, 37 (04) : 535 - 541
[34] CLINICAL-FEATURES AND PROGNOSIS OF ADULT POLYCYSTIC KIDNEY-DISEASE
GONZALO, A
RIVERA, M
QUEREDA, C
ORTUNO, J
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (06) : 470 - 474
[35] The spectrum of autosomal dominant polycystic kidney disease in children and adolescents
Reddy, Bharathi V.
Chapman, Arlene B.
PEDIATRIC NEPHROLOGY, 2017, 32 (01) : 31 - 42
[36] Adult Inactivation of the Recessive Polycystic Kidney Disease Gene Causes Polycystic Liver Disease
Besse, Whitney
Roosendaal, Charlotte
Tuccillo, Luigi
Roy, Sounak Ghosh
Gallagher, Anna-Rachel
Somlo, Stefan
KIDNEY360, 2020, 1 (10): : 1068 - 1076
[37] Primary Histiocytic Sarcoma in Adult Polycystic Kidney Disease: Case Report and Review of Literature
Krishnamurthy, Kritika
Delgado, Ruben
Kochiyil, Jyotsna
Medina, Ana Maria
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2021, 29 (03) : 321 - 326
[38] Chronic Kidney Disease and Albuminuria in Arterial Hypertension
Leoncini, Giovanna
Viazzi, Francesca
Pontremoli, Roberto
CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 335 - 341
[39] Pathophysiology of Resistant Hypertension in Chronic Kidney Disease
Campese, Vito M.
SEMINARS IN NEPHROLOGY, 2014, 34 (05) : 571 - 576
[40] Chronic Kidney Disease and Albuminuria in Arterial Hypertension
Giovanna Leoncini
Francesca Viazzi
Roberto Pontremoli
Current Hypertension Reports, 2010, 12 : 335 - 341

← 1 2 3 4 5 →